What:
Association of Cancer Care Centers (ACCC) 42nd Annual Meeting, CANCERSCAPE
When:
Wednesday, March 2 – Friday, March 4, 2016
Where:
Hyatt Regency Washington on Capitol Hill, Washington, D.C.
Anticipated Attendance: 400 cancer care providers and oncology healthcare leadersAs the U.S. healthcare system undergoes fundamental change, all stakeholders are being impacted — providers, patients, payers, physician practices, hospitals, and health systems. To gain strategic insight into the complex integrated oncology treatment landscape where clinical advances, policy mandates, and value-based payment reform intersect, leading experts in oncology care delivery will gather from March 2 – 4, 2016, in Washington, D.C., at the ACCC 42nd Annual Meeting, CANCERSCAPE.
From biosimiliars to emerging “value” frameworks to perspective on how Medicaid expansion may be affecting patient access to care, speakers will tackle the most pressing issues facing oncology care today, with a focus on policy, value, and quality. Congressman Richard "Rick" Nolan (D-MN) will open the meeting sessions, addressing upcoming oncology policy changes, as well as his family’s personal fight against lung cancer.
Meeting attendees will also be taking their message to Capitol Hill as they join their state delegations and make their voices heard for ACCC Capitol Hill Day on Wednesday, March 2, 2016. Multidisciplinary cancer team members will meet one-on-one with lawmakers to share how policy impacts oncology care in their community.
Meeting highlights include:
Featured SpeakerOncology on the “Hill”
U.S. Representative Richard Nolan
Thursday, March 3, 8:05 – 8:45 am
U.S. Representative Richard "Rick" Nolan will kick-off the Annual Meeting sessions on Thursday, March 3, speaking on "Oncology on the 'Hill.’” In January 2015, Congressman Nolan announced that his youngest daughter had been diagnosed with stage IV lung cancer. Congressman Nolan is the co-founding chair of the Congressional Lung Cancer Caucus.
Featured SpeakerCan Personalized Medicine and Value in Cancer Care Co-Exist?
Kavita Patel, MD, MS, The Brookings Institution
Thursday, March 3, 8:50 – 9:35 am
Dr. Kavita Patel will provide an explanation on how to reconcile the clinical imperatives of personalized medicine with the mandate to curb healthcare costs and demonstrate value.
Special Town Hall MeetingValue Framework Tools: The Provider Perspective
Thursday, March 3, 12:50 – 1:35 pm
Introduction: Steven L. D’Amato, BSPharm, BCOP, President, Association of Cancer Care Centers
Moderator: Christian Downs, JD, MHA, Executive Director, Association of Cancer Care Centers
Speakers: Alan Balch, PhD, Patient Advocate Foundation
Thomas A. Gallo, MS, Virginia Cancer Institute, Inc.
The emergence of oncology value frameworks from ASCO, NCCN, and ICER raise myriad practical questions for those on the frontlines of cancer care delivery. Panelists will address how can (or will) these tools improve patient care? What additional resources and education are needed so that providers understand both the methodology behind these tools and what role value frameworks may play in communicating about value, cost, and efficacy with the C-Suite, payers, and patients?
ACCC President’s ThemeKey Factors in Successful Integration
Thursday, March 3, 1:45 – 2:30 pm
Introduction: Steven L. D’Amato, BSPharm, BCOP, President, Association of Cancer Care Centers
Moderator: Christian Downs, JD, MHA, Executive Director, Association of Cancer Care Centers
Panelists: John D. Sprandio, MD, Consultants in Medical Oncology & Hematology, P.C.; Jessica Turgon, MBA, ECG Management Consultants; John Cox, DO, MBA, FACP, FASCO, UT Southwestern Medical Center
Healthcare mergers and acquisitions are occurring against a backdrop of site-neutral payment proposals, new reimbursement models, high price tag therapies, and the imperative to show value. What steps must hospitals and practices each take to ensure successful integration of services and financial viability, while strengthening delivery of quality care to cancer patients?
Sunrise Breakfast SessionUpdate on Biosimilars
Nisha Pherwani, PharmD, BCOP, Cardinal Health Innovative Delivery Solutions
Friday, March 4, 7:00 – 7:45 am
Dr. Nisha Pherwani will provide an overview of biosimilars development, the FDA approval process, and the challenges to integrating biosimilars into practice. In assessing biosimilars for inclusion in hospital formularies, what should Pharmacy and Therapeutics Committees take into account? Takeaways will include proactive steps for pharmacist-led biosimilar review at the oncology pharmacy.
Featured SpeakerMedicaid Expansion: The Patient Perspective
Alan Balch, PhD, Patient Advocate Foundation
Friday, March 4, 9:25 – 10:00 am
Given states’ varied Medicaid expansion decisions, how is patient access to care being impacted? This session will also focus on what navigating the insurance exchange is like for low-income patients attempting to maximize care access, improve health outcomes, and reduce financial burdens.
Additional Sessions
The meeting agenda includes discussions on the following topics:
December 21, 2021
December 21, 2021
September 13, 2021
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
